by Ed Tobias |
Now that a third COVID-19 vaccine shot has been approved in the U.S. for immunocompromised people, and vaccine boosters are expected to be available to the general public sometime after Sept. 20, Walgreens and CVS have lost no time in offering the additional shot to those who qualify.
Like their previous policies for vaccine shots and COVID-19 tests, the stores require people to make appointments online, and they’ll be happy to jab you.
But should you get that extra shot? For now, it depends on how immunosuppressed you are.
The U.S. Centers for Disease Control and Prevention (CDC), which recommended the third dose for immunocompromised people last week following special authorization for it by the U.S. Food and Drug Administration, said that people with compromised immune systems “may benefit from an additional dose to make sure they have enough protection against COVID-19.” The CDC, however, doesn’t specifically mention multiple sclerosis in their guidance, and not all people with MS have compromised immune systems.
In its guidance, the CDC stressed the importance of a third shot particularly for organ transplant recipients, stem cell transplant recipients, patients receiving cancer treatment, people with HIV, and others.
Additionally, in an announcement on Wednesday, the administration of U.S. President Joe Biden announced plans to offer booster shots to anyone who had received the two-shot Pfizer or Moderna vaccines eight months ago, starting with nursing home residents, healthcare workers, and emergency workers, The New York Times reported.
Which people with MS are immunocompromised?
By itself, MS doesn’t suppress the immune system. It’s actually the opposite. MS shifts the immune system into overdrive, hyping up cells that attack parts of the nervous system. Several disease-modifying therapies (DMTs), however, do suppress the immune system, which is how they halt those cellular attacks.
When you read that a third COVID-19 vaccine shot may be recommended for people with MS, it refers to the people whose immune systems are suppressed by one of these DMTs.
And as Chicago’s ABC7 pointed out, for immunocompromised people, a third shot isn’t really a booster, which is for people whose immunity has dissipated over time. Immunocompromised folks weren’t sufficiently protected in the first place by the initial two shots, ABC7 noted.
Immunosuppressive DMTs include Lemtrada (alemtuzumab), Mavenclad (cladribine), Gilenya (fingolimod), Ocrevus (ocrelizumab), and rituximab. It’s important to understand that each of these DMTs suppresses the immune system a bit differently and for different lengths of time.
For example, to be effective, Ocrevus needs to keep certain immune cells suppressed continuously. But these cells repopulate after about six months. That’s why Ocrevus treatment is required twice a year.
Lemtrada works differently. Some of those cells rebound quickly, while others may take a year or longer after a second Lemtrada treatment.
Click HERE to Subscribe for the MS Beacon eNewsletter
|
